BioCentury
ARTICLE | Clinical News

Aczone dapsone topical gel regulatory update

March 7, 2016 8:00 AM UTC

FDA approved Allergan’s Aczone dapsone 7.5% topical gel to treat acne vulgaris in patients ages >=12. The company already markets Aczone 5% in the U.S. and plans to launch the new product in May. Aczo...